Inner Cosmos is developing a brain-computer interface (BCI) to help patients with treatment … More
Inner Cosmos is a startup reinventing care for depressed patients unresponsive to conventional pharmaceutical therapies. Since the FDA granted the company a device exemption to initiate a feasibility study in 2022, they have fitted three patients with their Digital Pill device. This makes the company an early first mover in psychiatric brain-computer…
Continue Reading
News Source: www.forbes.com
Leave a Reply